Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

DTIL

PRECISION BIOSCIENCES INC

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1357874Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$34.0M
Net Income FY2025
$(46.0M)
EPS (Basic, as reported)
$-3.56
Net Margin FY2025
-133.4%
ROE FY2025
-49.6%
Total Equity
$92.0M
Shares Out
28M
Business description

PRECISION BIOSCIENCES INC — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 11 → 34 +17.5% CAGR
Fiscal yearFY2018FY2019FY2020FY2021⚑FY2022⚑FY2023⚑FY2024⚑FY2025
Revenue11222411625496934
Research & development(45)(82)(98)(115)(84)(53)(60)(54)
General & administrative(14)(27)(36)(40)(42)(39)(35)(32)
Total operating expenses(59)(109)(134)(155)(125)(92)(95)(86)
Operating income(48)(87)(110)(39)(100)(44)(26)(52)
Interest expense—0—0(1)(2)(2)(1)
Interest & investment income2410————
Other income (expense), net2(6)19(11)1336
Pre-tax income——————7(46)
Income tax expense——0———00
Net income(46)(93)(109)(31)(112)(61)7(46)
EPS — basic———($0.52)($1.27)($15.96)$1.05($3.56)
EPS — diluted———($0.52)($1.27)($15.96)$1.04($3.56)
Shares outstanding — basic (M)———59884713
Shares outstanding — diluted (M)———59884713
  • ⚑ Weighted-average shares changed ×1.49 between FY2021 and FY2022 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷20.00 between FY2022 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.75 between FY2023 and FY2024 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.86 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.